Genmab Wraps Up Leveraged Finance’s Biggest M&A Deal Since April
Why it matters
Genmab A/S completed a $4.5 billion acquisition funding deal, the largest in the US leveraged finance market since April, using junk bonds and a leveraged loan.
Expected market reaction
Market impact analysis based on bullish sentiment with 77% confidence.
Evidence trail
Evidence
Source
Bloomberg
Claim
Genmab Wraps Up Leveraged Finance’s Biggest M&A Deal Since April
AI inference
Bullish · 77%
Generated
2025-11-18 21:40
AI provenance
Technical identifiers
- Provider tag
- groq-llama-3.1-8b-instant
- Analysis version
- groq-llama-3.1-8b-instant
- Article id
- 12239
Original source
Genmab A/S completed the US leveraged finance market’s largest acquisition funding since April, raising $4.5 billion through junk bonds and a leveraged loan.
Read the full article on Bloomberg
Original article published by Bloomberg on November 19, 2025. Analysis and insights provided by AnalystMarkets AI.